[1. KOLH P, WINDECKER S, ALFONSO F, COLLET J-P, CREMER J, FALK V et al. 2014 ESC/EACTS guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European journal of cardio-thoracic surgery 2014, 46 (4):517-592.]Search in Google Scholar
[2. MACK MJ, BROWN PP, KUGELMASS AD, BATTAGLIA SL, TARKINGTON LG, SIMON AW et al. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. The Annals of thoracic surgery 2004, 77 (3):761-766; discussion 766-768.10.1016/j.athoracsur.2003.06.019]Search in Google Scholar
[3. MINTZ GS, HOFFMANN R, MEHRAN R, PICHARD AD, KENT KM, SATLER LF et al. In-stent restenosis: the Washington Hospital Center experience. The American journal of cardiology 1998, 81 (7a):7e-13e.10.1016/S0002-9149(98)00190-8]Search in Google Scholar
[4. MORRIS RE. Mechanisms of action of new immunosuppressive drugs. Therapeutic drug monitoring 1995, 17 (6):564-569.10.1097/00007691-199512000-00003]Search in Google Scholar
[5. MARX SO, MARKS AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001, 104 (8):852-855.10.1161/01.CIR.104.8.852]Search in Google Scholar
[6. STONE GW, ELLIS SG, CANNON L, MANN JT, GREENBERG JD, SPRIGGS D et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005, 294 (10):1215-1223.10.1001/jama.294.10.1215]Search in Google Scholar
[7. KASTRATI A, MEHILLI J, VON BECKERATH N, DIBRA A, HAUSLEITER J, PACHE J et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005, 293 (2):165-171.10.1001/jama.293.2.165]Search in Google Scholar
[8. COSTA MA, SIMON DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005, 111 (17):2257-2273.10.1161/01.CIR.0000163587.36485.A7]Search in Google Scholar
[9. KORNOWSKI R, HONG MK, TIO FO, BRAMWELL O, WU H, LEON MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998, 31 (1):224-230.10.1016/S0735-1097(97)00450-6]Open DOISearch in Google Scholar
[10. HOFFMANN R, MINTZ GS, DUSSAILLANT GR, POPMA JJ, PICHARD AD, SATLER LF et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996, 94 (6):1247-1254.10.1161/01.CIR.94.6.1247]Search in Google Scholar
[11. SERRUYS PW, KAY IP, DISCO C, DESHPANDE NV, DE FEYTER PJ. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol 1999, 34 (4):1067-1074.10.1016/S0735-1097(99)00308-3]Open DOISearch in Google Scholar
[12. WELT FG, EDELMAN ER, SIMON DI, ROGERS C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arteriosclerosis, thrombosis, and vascular biology 2000, 20 (12):2553-2558.10.1161/01.ATV.20.12.2553]Search in Google Scholar
[13. HORVATH C, WELT FG, NEDELMAN M, RAO P, ROGERS C. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circulation research 2002, 90 (4):488-494.10.1161/hh0402.10595611884380]Search in Google Scholar
[14. KAWAMOTO R, YAMASHITA A, NISHIHIRA K, FURUKOJI E, HATAKEYAMA K, ISHIKAWA T et al. Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits. Pathology, research and practice 2006, 202 (6):447-456.10.1016/j.prp.2005.12.01116635553]Search in Google Scholar
[15. VIRMANI R, GUAGLIUMI G, FARB A, MUSUMECI G, GRIECO N, MOTTA T et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004, 109 (6):701-705.10.1161/01.CIR.0000116202.41966.D414744976]Search in Google Scholar
[16. NEBEKER JR, VIRMANI R, BENNETT CL, HOFFMAN JM, SAMORE MH, ALVAREZ J et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006, 47 (1):175-181.10.1016/j.jacc.2005.07.07116386683]Open DOISearch in Google Scholar
[17. GABBASOV ZA, KOZLOV SG, LYAKISHEV AA, SABUROVA OS, SMIRNOV VA, SMIRNOV VN. Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents. Canadian journal of physiology and pharmacology 2009, 87 (2):130-136.10.1139/Y08-10719234576]Search in Google Scholar
[18. MELO RC, SPENCER LA, DVORAK AM, WELLER PF. Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. Journal of leukocyte biology 2008, 83 (2):229-236.10.1189/jlb.0707503273494917875811]Search in Google Scholar
[19. VENGE P, BYSTROM J, CARLSON M, HAKANSSON L, KARAWACJZYK M, PETERSON C et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clinical and experimental allergy: Journal of the British Society for Allergy and Clinical Immunology 1999, 29 (9):1172-1186.10.1046/j.1365-2222.1999.00542.x10469025]Open DOISearch in Google Scholar
[20. MEMON S, CHHABRA L, MASRUR S, PARKER MW. Allergic acute coronary syndrome (Kounis syndrome). Proceedings (Baylor University Medical Center) 2015, 28 (3):358-362.10.1080/08998280.2015.11929274446222226130889]Search in Google Scholar
[21. KOUNIS NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 2006, 110 (1):7-14.10.1016/j.ijcard.2005.08.00716249041]Search in Google Scholar
[22. CRANS YOON AM, CHIU V, RANA JS, SHEIKH J. Association of allergic rhinitis, coronary heart disease, cerebrovascular disease, and all-cause mortality. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 2016, 117 (4):359-364. e351.10.1016/j.anai.2016.08.021]Search in Google Scholar
[23. KOSTER R, VIELUF D, KIEHN M, SOMMERAUER M, KAHLER J, BALDUS S et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000, 356 (9245):1895-1897.10.1016/S0140-6736(00)03262-1]Search in Google Scholar
[24. EL-MAWARDY R, FUAD H, ABDEL-SALAM Z, GHAZY M, NAMMAS W. Does nickel allergy play a role in the development of in-stent restenosis? European review for medical and pharmacological sciences 2011, 15 (11):1235-1240.]Search in Google Scholar
[25. HILLEN U, HAUDE M, ERBEL R, GOOS M. Evaluation of metal allergies in patients with coronary stents. Contact dermatitis 2002, 47 (6):353-356.10.1034/j.1600-0536.2002.470607.x]Open DOISearch in Google Scholar
[26. NORGAZ T, HOBIKOGLU G, SERDAR ZA, AKSU H, ALPER AT, OZER O et al. Is there a link between nickel allergy and coronary stent restenosis? The Tohoku journal of experimental medicine 2005, 206 (3):243-246.10.1620/tjem.206.243]Search in Google Scholar
[27. OTSUKA Y, NAKAMURA M, KOKUBU N, TONOOKA A, INOUE K, HIGAMI T. Diffuse in-stent restenosis of CYPHER(R) stent due to hypersensitivity reaction confirmed by pathohistological findings. Heart and vessels 2012, 27 (1):110-113.10.1007/s00380-011-0145-1]Search in Google Scholar
[28. YAGI H, AMIYA E, ANDO J, WATANABE M, YANABA K, IKEMURA M et al. In-Stent Restenosis Exacerbated by Drug-Induced Severe Eosinophilia after Second-Generation Drug-Eluting Stent Implantation. The American Journal of Case Reports 2014, 15:397-400.10.12659/AJCR.891106]Search in Google Scholar
[29. GREWE PH, DENEKE T, MACHRAOUI A, BARMEYER J, MULLER KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000, 35 (1):157-163.10.1016/S0735-1097(99)00486-6]Open DOISearch in Google Scholar
[30. RITTERSMA SZ, MEUWISSEN M, VAN DER LOOS CM, KOCH KT, DE WINTER RJ, PIEK JJ et al. Eosinophilic infiltration in restenotic tissue following coronary stent implantation. Atherosclerosis 2006, 184 (1):157-162.10.1016/j.atherosclerosis.2005.03.04915950231]Search in Google Scholar
[31. TAKASHIMA A, SHIMABUKURO M, TABATA M, FUKUDA D, UEMATSU E, ISHIBASHI-UEDA H et al. Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology 2015, 24 (3):194-197.10.1016/j.carpath.2014.11.00225483741]Search in Google Scholar
[32. GABBASOV ZA, KOZLOV SG, SABUROVA OS, TITIOV VN, LIAKISHEV AA. [Stromal progenitor cells and blood leukocytes after implantation of drug-eluting stents]. Kardiologiia 2010, 50 (1):36-41.]Search in Google Scholar
[33. GABBASOV ZA, KOZLOV SG, IMAEVA AE, SABUROVA OS, ZYKOV KA, MASENKO VP et al. In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein. Canadian journal of physiology and pharmacology 2011, 89 (6):413-418.10.1139/y11-03821751895]Search in Google Scholar
[34. MEHILLI J, KASTRATI A, BOLLWEIN H, DIBRA A, SCHUHLEN H, DIRSCHINGER J et al. Gender and restenosis after coronary artery stenting. Eur Heart J 2003, 24 (16):1523-1530.10.1016/S0195-668X(03)00320-8]Open DOISearch in Google Scholar
[35. CHEN SJ, LI H, DURAND J, OPARIL S, CHEN YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996, 93 (3):577-584.10.1161/01.CIR.93.3.577]Open DOISearch in Google Scholar
[36. GRUNERT G, PORCIA M, TCHERNITCHIN AN. Differential potency of oestradiol-17 beta and diethylstilboestrol on separate groups of responses in the rat uterus. The Journal of Endocrinology 1986, 110 (1):103-114.10.1677/joe.0.1100103]Search in Google Scholar
[37. SCHWINGSHACKL A, DUSZYK M, BROWN N, MOQBEL R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. The Journal of allergy and clinical immunology 1999, 104 (5):983-989.10.1016/S0091-6749(99)70079-5]Search in Google Scholar
[38. KATSAROS KM, KASTL SP, ZORN G, MAURER G, WOJTA J, HUBER K et al. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and-9. JACC: Cardiovascular Interventions 2010, 3 (1):90-97.10.1016/j.jcin.2009.10.02320129576]Search in Google Scholar
[39. FUKUI M, TANAKA M, HAMAGUCHI M, SENMARU T, SAKABE K, SHIRAISHI E et al. Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes. Clinical Journal of the American Society of Nephrology: CJASN 2009, 4 (11):1761-1765.10.2215/CJN.03330509277495919808222]Search in Google Scholar